Alnylam Pharmace. buy Wolf_of_WS
Summary
This prediction ended on 24.06.24 with a price of €209.40. The BUY prediction by Wolf_of_WS for Alnylam Pharmace. saw massive gains of 35.23%. Wolf_of_WS has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
Name | 1w |
---|---|
Alnylam Pharmace. | 2.115% |
iShares Core DAX® | 1.395% |
iShares Nasdaq 100 | 2.287% |
iShares Nikkei 225® | 1.617% |
iShares S&P 500 | 0.659% |
According to Wolf_of_WS what are the pros and cons of Alnylam Pharmace. for the foreseeable future?
Pros
Cons
Comments by Wolf_of_WS for this prediction
In the thread Alnylam Pharmace. diskutieren
In the thread Trading Alnylam Pharmace.